Hasil Pencarian - Mark David Levin

Perbaiki Hasil
  1. 1
    New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia

    New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia oleh Peter E. Westerweel, Peter E. Westerweel, Peter A. W. te Boekhorst, Mark-David Levin, Mark-David Levin, Jan J. Cornelissen

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Diagnostics in anaemia of chronic disease in general practice: a real-world retrospective cohort study

    Diagnostics in anaemia of chronic disease in general practice: a real-world retrospective cohort study oleh Annemarie Schop, Karlijn Stouten, Ron van Houten, Jürgen Riedl, Joost van Rosmalen, Patrick JE Bindels, Mark-David Levin

    Diterbitkan 2018-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice

    Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice oleh Camille C.B. Kockerols, Peter J.M. Valk, Mark-David Levin, Niels Pallisgaard, Jan J. Cornelissen, Peter E. Westerweel

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice

    Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice oleh Michelle M. A. Kip, Martijn L. J. Oonk, Mark-David Levin, Annemarie Schop, Patrick J. E. Bindels, Ron Kusters, Hendrik Koffijberg

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the Netherlands

    Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the Netherlands oleh Lina van derStraten, Mark‐David Levin, Otto Visser, Eduardus F.M. Posthuma, Jeanette K. Doorduijn, Arnon P. Kater, Avinash G. Dinmohamed

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study

    Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study oleh Chantal Visser, Marieke J. H. A. Kruip, Janet Brantsma-Van der Graaf, Eric E. van Thiel, Mark-David Levin, Peter E. Westerweel

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

    Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice oleh Nathalie I. Bouwer, Agnes Jager, Crista Liesting, Marcel J.M. Kofflard, Jasper J. Brugts, Jos J.E.M. Kitzen, Eric Boersma, Mark-David Levin

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTERRUPTING TLR9-INDUCED CD40 UPREGULATION AND PROTEIN TRANSLATION

    S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTERRUPTING TLR9-INDUCED CD40 UPREGULATION AND PROTEIN TRANSLATION oleh Karoline Kielbassa, Marco Haselager, Danique Bax, Bianca van Driel, Mark-David Levin, Sabina Kersting, Rebecka Svanberg, Carsten U. Niemann, Arnon P. Kater, Eric Eldering

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN): RESULTS FROM THE PHASE 3 GLOW STUDY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL

    P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN): RESULTS FROM THE PHASE 3 GLOW STUDY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL oleh Arnon Kater, Brandon Hodkinson, Carol Moreno, Talha Munir, Mark-David Levin, Carsten Niemann, Keqin Qi, Pierre Sinet, Kurt Baeten, Donne Bennett Caces, Srimathi Srinivasan

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

    The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era oleh Camille C.B. Kockerols, Inge Geelen, Mark-David Levin, Jeroen J.W.M. Janssen, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab

    2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab oleh Nathalie I. Bouwer, Crista Liesting, Marcel J. M. Kofflard, Jasper J. Brugts, Marc C. J. Kock, Jos J. E. M. Kitzen, Mark-David Levin, Eric Boersma

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

    Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features oleh Lina van der Straten, Lina van der Straten, Lina van der Straten, Paul J. Hengeveld, Paul J. Hengeveld, Arnon P. Kater, Anton W. Langerak, Mark-David Levin

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019

    Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019 oleh Lina van der Straten, Mark-David Levin, Manette A. W. Dinnessen, Otto Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, Anton W. Langerak, Arnon P. Kater, Avinash G. Dinmohamed

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018

    Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018 oleh Lina van der Straten, Carolien C. H. M. Maas, Mark-David Levin, Otto Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, Anton W. Langerak, Arnon P. Kater, Avinash G. Dinmohamed

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population

    High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population oleh Camille C.B. Kockerols, Inge G.P. Geelen, Mark-David Levin, Jeroen J.W.M. Janssen, H. Berna Beveloo, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

    NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab oleh Nathalie I. Bouwer, Crista Liesting, Marcel J. M. Kofflard, Sylvia M. Sprangers-van Campen, Jasper J. Brugts, Jos J. E. M. Kitzen, Michael A. Fouraux, Mark-David Levin, Eric Boersma

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients

    The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients oleh Leni van Doorn, Marie-Rose B. S. Crombag, Hánah N. Rier, Jeroen L. A. van Vugt, Charlotte van Kesteren, Sander Bins, Ron H. J. Mathijssen, Mark-David Levin, Stijn L. W. Koolen

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry

    Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry oleh Ruth Wester, Avinash G. Dinmohamed, Bronno van der Holt, Sonja Zweegman, Monique Minnema, Sandra Croockewit, Mark-David Levin, Eduard Libourel, Esther de Waal, Pieter Sonneveld, Jan Cornelissen, Nicole Blijlevens, Annemiek Broijl

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL

    Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL oleh Tom Hofland, Iris de Weerdt, Sanne Endstra, Aldo Jongejan, Laura Platenkamp, Ester B.M. Remmerswaal, Perry D. Moerland, Ineke J.M. ten Berge, Mark-David Levin, Arnon P. Kater, Sanne H. Tonino

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice

    Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice oleh Simone Oerlemans, M. Christine Bennink, Mark David Levin, Annemiek Broijl, Marjolein Van der Klift, Judith Van Deursen, Daphne Vogels, Lonneke V. Van de Poll-Franse, Pieter Sonneveld, Jan A. Hazelzet, Lidwine W. Tick

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: